Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
As of close of business last night, Cabaletta Bio Inc’s stock clocked out at $1.66, down -3.49% from its previous closing price of $1.72. In other words, the price has decreased by -$3.49 from its previous closing price. On the day, 0.73 million shares were traded. CABA stock price reached its highest trading level at $1.71 during the session, while it also had its lowest trading level at $1.635.
Ratios:
To gain a deeper understanding of CABA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.11 and its Current Ratio is at 8.11. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Evercore ISI on December 20, 2024, Downgraded its rating to In-line and sets its target price to $6 from $15 previously.
On December 19, 2024, Wells Fargo Downgraded its rating to Equal Weight which previously was Overweight and also lowered its target price recommendation from $12 to $6.
On October 10, 2024, UBS started tracking the stock assigning a Buy rating and target price of $10.UBS initiated its Buy rating on October 10, 2024, with a $10 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CABA now has a Market Capitalization of 81136152 and an Enterprise Value of -86651904.
Stock Price History:
The Beta on a monthly basis for CABA is 2.38, which has changed by -0.903207 over the last 52 weeks, in comparison to a change of 0.10063088 over the same period for the S&P500. Over the past 52 weeks, CABA has reached a high of $19.04, while it has fallen to a 52-week low of $1.59. The 50-Day Moving Average of the stock is -22.60%, while the 200-Day Moving Average is calculated to be -61.75%.
Shares Statistics:
It appears that CABA traded 1.21M shares on average per day over the past three months and 769740 shares per day over the past ten days. A total of 48.85M shares are outstanding, with a floating share count of 44.47M. Insiders hold about 9.03% of the company’s shares, while institutions hold 74.15% stake in the company. Shares short for CABA as of 1741910400 were 6229073 with a Short Ratio of 5.59, compared to 1739491200 on 6202915. Therefore, it implies a Short% of Shares Outstanding of 6229073 and a Short% of Float of 13.170000000000002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The current market rating for Cabaletta Bio Inc (CABA) reflects the collective analysis of 6.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.67, with high estimates of -$0.46 and low estimates of -$0.74.
Analysts are recommending an EPS of between -$1.56 and -$2.41 for the fiscal current year, implying an average EPS of -$2.21. EPS for the following year is -$2.77, with 6.0 analysts recommending between -$1.84 and -$3.25.
